Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Aug;19(8):1128-1132.
doi: 10.1016/j.jtho.2024.05.376.

Benefit With No Target: Long-Term Outcomes of Chemoimmunotherapy in "PD-L1 Negative" NSCLC

Affiliations
Free article
Editorial

Benefit With No Target: Long-Term Outcomes of Chemoimmunotherapy in "PD-L1 Negative" NSCLC

Fabiana Perrone et al. J Thorac Oncol. 2024 Aug.
Free article
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosure Dr. Perrone reports receiving travel support from Merck Sharp & Dohme and Novartis and having participation on an advisory board of Novartis. Dr. Leonetti reports receiving speakers’ fees from AstraZeneca, Merck Sharp & Dohme, Sanofi, and Takeda; serving on the advisory boards of AstraZeneca, BeiGene, Novartis, and Sanofi; having editorial activities sponsored by Eli Lilly and Roche; and receiving travel support from Merck Sharp & Dohme and Novartis. Dr. Tiseo reports receiving speakers’ and consultants’ fees from AstraZeneca, Pfizer, Eli Lilly, Bristol Myers Squibb, Novartis, Roche, Merck Sharp & Dohme, Boehringer Ingelheim, Takeda, Amgen, Merck, Sanofi, Janssen, and Daiichi Sankyo; institutional research grants from AstraZeneca, Boehringer Ingelheim, and Roche; and travel support from Amgen and Takeda. Dr. Facchinetti reports serving on the advisory board of BeiGene.

Publication types

MeSH terms